Background
The semen quality can be affected considerably by abstinence times and will define the first-line treatment options for infertility couples undergoing assisted reproductive technologies. Studies have evaluated that the duration of abstinence affects both conventional sperm parameters (volume, sperm concentration, motility, and morphology) and SDF [1–3]. It is well-accepted that semen volume and sperm concentration will increase with prolonged abstinence, but such abstinence can have a negative impact on motility and viability. Likewise, ejaculates from men with oligozoospermia exhibited a significant improvement in sperm motility, progression, and morphology when a second ejaculate was produced within only 40 min of the first [4]. Additionally, when a second ejaculation was collected within 1 to 3 h of the first ejaculation, the second ejaculation of men showed a significant enhancement in terms of total motility sperm count [4, 5]. Second ejaculation may reduce the use of ICSI by providing more available good-quality spermatozoa. Although many studies have found the impact of second ejaculation on sperm quality, further research is still needed to determine whether second ejaculation can provide sufficient progressive motility sperm for IVF in unexpected ICSI patients.
ICSI was originally applied to overcome the most severe forms of male factor infertility [6]. Nowadays, the use of ICSI for patients with borderline or even normal semen parameters has become more common [7]. Despite the widespread use of ICSI, evidence to support the use of ICSI in different infertility cases is still debatable. Recently, studies found that ICSI did not improve the overall clinical outcomes compared with IVF in the treatment of non-severe male and non-male factor infertility [8, 9]. As an invasive operating technique, ICSI may affect the decondensation of spermatozoa and may disrupt the oocyte meiotic spindle during the spermatozoon injection into the oocyte cytoplasm [10–12]. Furthermore, ICSI may be associated with increased risk of autism, intellectual impairment and genitourinary malformation in offspring than IVF-conceived children [13, 14]. In addition, compared with conventional IVF, ICSI may need the increased required laboratory experience, resources, effort, and time [7]. Given the effectiveness, safety, and costs of ICSI, we should follow the sperm characteristics of Chinese expert consensus on ICSI patients [15].
Moreover, it is noteworthy that SDF can be significantly diminished by short-term ejaculation [16]. Compromised spermatozoa quality varies with different sexual abstinence and may influence SDF as well as pregnancy outcomes [2, 17]. A recent sperm proteome study has proposed that the molecular events occurring in sperm proteins may play an important role in sperm quality and reproductive potential after reduced periods of male ejaculatory abstinence [18]. Therefore, how to correctly evaluate the outcomes of second ejaculation IVF would contribute to reasonably judge the effectiveness of second ejaculation IVF in reducing the use of ICSI.
Second ejaculation was requested from patients who presented unexpected ICSI on the day of treatment. We compared semen parameters between the first and second samples with the aim of verifying if the second ejaculation could be a good strategy for obtaining enough progressive motile sperm for IVF. Furthermore, outcomes of fertilization, embryo quality, and pregnancy in second ejaculation IVF patients, were compared with propensity score matched-conventional IVF patients who produced a single semen sample, in order to evaluate the effectiveness of second ejaculation IVF.
Methods
Study design and participants
In this retrospective single-center study, we obtained data from 2782 infertile couples who were projected to undergo IVF at our hospital between January 2016 and November 2021. Patients with severe oligozoospermia (concentration < 1 × 106/mL), severe asthenozoospermia (progressive motility < 1%), and other ICSI indications [15] were excluded. All procedures were performed in accordance with the ethical standards of the ethics committee of our hospital (No: LL-KY-ZC-2021-02) and with the 1964 Declaration of Helsinki and its later amendments. The first ejaculation after swim-up was checked on the day of ovum pick-up, 143 unexpected ICSI patients were found with the sperm under the conventional ICSI criteria (progressive motility < 1 × 106). 114 of them refused to undergo ICSI and provided a second semen sample 1–3 h after the first semen collection. Patients with a total progressive motile sperm count enough for IVF of the second ejaculation were included in the second ejaculation IVF group (n = 61). Patients with traditional IVF were assessed as the conventional IVF group (n = 2639). A flow chart for patient recruitment is shown in Fig. 1.
Fig. 1 [Images not available. See PDF.]
A flow chart for patient recruitment
PSM
As the second ejaculation was not randomized, to reduce the differences in baseline characteristics of the patient, a propensity score was used to adjust for potential selection or predisposition bias. We calculated PSM analyses using a logistic regression model by R version 4.3.1 software. These covariates included female age, male age, number of oocytes retrieved, ovarian stimulation protocol, infertility types, concentration after swim-up, progressive motility after swim-up and total progressive motile sperm count after swim-up based on prior knowledge. After the propensity scores were estimated, patients were selected by 1:4 nearest neighbor matching including replacement and a caliper of 0.2.
Semen handling and analysis
Semen samples were obtained in a private room by masturbation into a sterile wide-mouthed plastic container. After liquefaction at 37 °C for 30 min, the samples were assessed under an inverted microscope at × 200 magnification. Semen analysis was performed according to the fifth edition of the World Health Organization guidelines and included sperm concentration and motility. A Sperm Class Analyzer CASA system (Microptic S.L., Barcelona, Spain) was used to assess sperm concentration and motility. Motile sperm fractions were isolated after density gradients and the “swim-up” process. Morphology was assessed by smearing 10 μL of the semen samples and subsequently washed and fixed using MGG Quick Stain (Bio-optica, Milan, Italy). The SDF was assessed by the sperm chromatin dispersion test using the Halosperm kit (Halotech DNA S.L., Madrid, Spain).
Ovarian stimulation protocols
When more than three follicles were larger than 18 mm in diameter, a dose of 5000–10,000 IU human chorionic gonadotropin was injected intramuscularly. After 36–40 h oocytes were retrieved under ultrasonographic guidance. According to clinical indications, the patient underwent conventional IVF 3–5 h after oocyte retrieval. When the amount of second polar bodies released from mature oocytes was less than 30%, the culture was continued for more than 2 h and then the second PB exposure was checked again. When < 50% of the mature oocytes were exposed to the second PB, rescue ICSI was carried out immediately for the oocytes with only one PB. The operation of rescue ICSI was like that of conventional ICSI.
Embryo assessment and embryo transfer protocols
All oocytes were cultured in a culture medium with 6% CO2, 5% O2, and 89% N2 at 37 °C. Conventional morphology, cell count, cleavage patterns, and degree of fragmentation scores of the embryos were determined. To minimize operator-dependent variations, especially in blastocyst annotation, two embryologists were specifically trained, and annotation was performed according to the published guidelines. Good quality embryos were defined as having 8 to 10 cells, no embryo fragmentation, and cells that were very even, regular, and similarly sized.
Fresh embryo transfer was performed on day 3 or day 5 based on the number of embryos available and their quality according to clinic protocol. Intramuscular progesterone, 50 mg per day, was begun on the day after oocyte retrieval for those undergoing a fresh transfer and continued until 10 weeks of gestation if conception occurred.
Confirmation of pregnancy
If β-hCG was detected in the blood 14 days after egg collection, the trace test after 1 week showed a continuous increase, and vaginal ultrasonography performed at 6 to 7 weeks of pregnancy showed a gestational sac, then clinical pregnancy was verified. The implantation rate was calculated as the percentage of embryonic sacs implanted in the uterus that became implanted embryos. Miscarriage was defined as a fetal loss prior to 12 weeks of gestation despite the presence of a gestational sac in the first-trimester ultrasound.
Statistical analysis
The results are expressed as mean ± standard deviation or proportions (%). Student’s t test was used to compare the clinical baseline data of continuous variables between the two groups, and the Mann–Whitney U test was used to compare continuous variables with a skewed distribution. The chi-square test was used to compare categorical data between groups. Univariate and multivariate linear regression were performed to identify independent risk factors for clinical outcomes. All statistical tests were two-sided, and values were considered significant at P < 0.05. All statistical analyses were performed using the statistical package SPSS V.22.0 (IBM Co., Armonk, NY, USA).
Results
One hundred fourteen patients were treated with two ejaculates of unexpected ICSI couples. The sperm parameters of two ejaculates were compared. There were significant differences in semen volume, concentration, total sperm count, progressive motility, SDF, and both concentration, progressive motility, total progressive motility sperm count, SDF after swim-up between the two ejaculates (all P < 0.05), but no significant differences were found in total progressive motile sperm count, sperm morphology, and sperm morphology after swim-up (P = 0.588, P = 0.355, P = 0.112, respectively). Sixty-one of 114 (53.5%) unexpected ICSI couples had enough total progressive motility sperm with second ejaculation for IVF (Table 1).
Table 1. Comparison of sperm parameters between the two ejaculates of unexpected ICSI couples
Parameters | 1st | 2nd | P |
|---|---|---|---|
Volume | 2.00 (1.50,3.00) | 1.0 (0.80,2.00) | <0.001 |
Concentration (million/mL) | 14.65 (10.00,24.70) | 21.70 (10.15,39.25) | 0.038 |
Total sperm count (million) | 35.05 (16.45,60.13) | 22.50 (14.68,39.10) | 0.009 |
Progressive motility (%) | 13.00 (5.05,24.30) | 21.55 (11.75,32.85) | 0.001 |
Total progressive motile sperm count (million) | 3.99 (1.34,8.19) | 4.32 (1.45,9.50) | 0.588 |
Morphology (%) | 1.00 (1.00,2.00) | 1.00 (1.00,3.00) | 0.355 |
SDF | 39.50 (26.00,59.00) | 28.00 (17.00,42.00) | 0.014 |
Concentration after swim-up (million/mL) | 1.70 (0.95,2.50) | 2.90 (1.05,5.40) | 0.003 |
Progressive motility after swim-up (%) | 69.10 (58.30,78.70) | 73.10 (59.00,86.80) | 0.003 |
Total progressive motile sperm count after swim-up (million) | 0.67 (0.31,1.08) | 1.04 (0.38,2.38) | < 0.001 |
Morphology after swim-up (million) (%) | 1.0 0 (1.00,2.00) | 1.50 (1.00,2.00) | 0.112 |
SDF after swim-up (million) | 8.00 (5.00,12.00) | 5.00 (3.00,8.00) | 0.005 |
Total progressive motile sperm count enough for IVF (%) | 0/114 (0.0) | 61/114 (53.5) | / |
Comparisons of the basic characteristics between the second ejaculation IVF and conventional IVF before and after PSM are shown in Table 2. The PSM analysis was performed to reduce the inter-group imbalances in the baseline data (Fig. 2). Before PSM, the concentration (P < 0.001) and total progressively motile sperm count after swim-up (P < 0.001) were significantly lower in second ejaculation IVF group than in conventional IVF group. After 1:4 PSM, we matched 61 cases in the second ejaculation IVF group to 238 controls in the matched-conventional IVF. There were no significant differences in any of the baseline characteristics between the two groups (all P > 0.05).
Table 2. Baseline patient characteristics in second ejaculation IVF and conventional IVF before and after propensity score matching
Baseline characteristics | Second ejaculation IVF n = 61 | Conventional IVF n = 2639 | P value | Matched-conventional IVF n = 238 | P value |
|---|---|---|---|---|---|
Female age | 33.50 ± 5.09 | 34.31 ± 7.71 | 0.413 | 33.26 ± 4.56 | 0.712 |
Male age | 36.10 ± 5.56 | 35.92 ± 5.94 | 0.823 | 35.68 ± 5.87 | 0.617 |
Number of oocytes retrieved | 10.00 (4.00, 13.00) | 9.00 (5.00,13.00) | 0.591 | 8.00 (5.00, 12.00) | 0.710 |
Ovarian stimulation protocol n (%) | |||||
Long-acting protocol | 11 (18.0) | 509 (19.3) | 0.096 | 59 (24.8) | 0.307 |
Short-acting protocol | 29 (47.5) | 913 (34.6) | 89 (37.4) | ||
Others | 21 (34.4) | 1217 (46.1) | 90 (37.8) | ||
Primary infertility (%) | 25 (41.0) | 988 (37.4) | 0.572 | 92 (38.7) | 0.740 |
Secondary infertility (%) | 36 (59.0) | 1651 (62.6) | 146 (61.3) | ||
Concentration after swim-up (million/mL) | 5.25 (3.75, 8.60) | 20.40 (9.90, 37.40) | < 0.001 | 5.20 (3.30, 9.90) | 0.904 |
Progressive motility after swim-up (%) | 86.65 (76.40, 93.15) | 88.90 (79.50, 94.20) | 0.109 | 83.85 (72.30, 91.30) | 0.203 |
Total progressive motile sperm count after swim-up (million) | 2.24 (1.52, 2.94) | 8.67 (4.06, 16.32) | < 0.001 | 2.13 (1.30, 3.55) | 0.777 |
Fig. 2 [Images not available. See PDF.]
Distribution of propensity scores in the second ejaculation IVF, conventional IVF, and matched-conventional IVF groups
The clinical outcomes between the second ejaculation IVF group and the matched-conventional IVF group are shown in Table 3. No significant differences in terms of 2PN fertilization rate, total fertilization rate, rescue ICSI rate, cleavage rate, good quality embryo rate on day 3, blastocyst formation rate, and clinical outcomes were observed between the two groups (all P > 0.05). There was a higher good-quality blastocyst rate in the second ejaculation IVF group compared with matched-conventional IVF groups (35.1% vs. 26.1%, P = 0.026).
Table 3. Embryological and clinical outcomes comparison between the second ejaculation IVF and matched-conventional IVF
Variable | Second ejaculation IVF | Matched-conventional IVF | P value |
|---|---|---|---|
2PN fertilization rate | 324/559 (58.0) | 1318/2158 (61.1) | 0.180 |
Total fertilization rate | 434/559 (77.6) | 1659/2158 (76.9) | 0.703 |
Rescue ICSI rate | 3/61 (4.9) | 24/238 (10.1) | 0.316 |
Cleavage rates | 423/434 (97.5) | 1632/1659 (98.4) | 0.208 |
Good-quality embryo rate on day 3 | 165/320 (51.6) | 595/1298 (45.8) | 0.066 |
Blastocyst formation rate | 148/229 (64.6) | 652/936 (69.7) | 0.141 |
Good-quality blastocyst rate | 52/148 (35.1) | 170/652 (26.1) | 0.026 |
Biochemical pregnancy | 17/23 (73.9) | 68/126 (31.0) | 0.168 |
Clinical pregnancy rate | 19/46 (41.3) | 78/252 (52.2) | 0.382 |
Implantation rate | 16/23 (66.7) | 62/126 (49.7) | 0.117 |
Live birth rate | 13/23 (56.5) | 51/126 (40.5) | 0.153 |
Miscarriage rate | 3/23 (13.0) | 8/126 (6.3) | 0.259 |
To analyze the risk factors associated with the good quality blastocyst rate, univariate and multivariate regression linear analyses were conducted (Table 4). The univariate analysis showed that second ejaculation (coefficient, 0.173; SE, 0.054; P = 0.014) and secondary infertility (Coefficient, 0.152; SE, 0.043; P = 0.031) were related to the good quality blastocyst rate. Further multivariate analysis confirmed that second ejaculation (coefficient, 0.168; SE, 0.055; P = 0.020) was an independent risk factor for the good quality blastocyst rate.
Table 4. Univariate and multivariate linear regression analyses of risk factors for good quality blastocyst rate
Factor | Univariate Coefficient | SE | P value | Multivariate Coefficient | SE | P value |
|---|---|---|---|---|---|---|
Second ejaculation | 0.173 | 0.054 | 0.014 | 0.168 | 0.055 | 0.020 |
Female age (years) | − 0.088 | 0.005 | 0.218 | 0.019 | 0.007 | 0.854 |
Male age (years) | − 0.092 | 0.004 | 0.196 | -0.094 | 0.005 | 0.333 |
Number of oocytes retrieved | − 0.012 | 0.004 | 0.863 | -0.038 | 0.004 | 0.606 |
Ovarian stimulation protocol) | ||||||
Long-acting protocol | ||||||
Short-acting protocol | 0.111 | 0.052 | 0.203 | 0.085 | 0.053 | 0.335 |
Others | 0.098 | 0.057 | 0.259 | 0.071 | 0.058 | 0.423 |
Primary infertility | ||||||
Secondary infertility | 0.152 | 0.043 | 0.031 | 0.124 | 0.047 | 0.108 |
Concentration after swim-up | − 0.004 | 0.002 | 0.958 | 0.772 | 0.025 | 0.473 |
Progressive motility after swim-up | − 0.080 | 0.002 | 0.260 | -0.017 | 0.003 | 0.893 |
Total progressive motile sperm count after swim-up | − 0.013 | 0.004 | 0.851 | -0.771 | 0.056 | 0.479 |
Discussion
Despite the wide use of ICSI, its effectiveness in patients with non-severe male infertility is still debatable. The semen fluid characteristics on the day of ovum pick-up with male infertility patients create an increase in unexpected ICSI. Most studies have demonstrated an improvement in sperm quality following second ejaculation [1, 2, 4, 16, 17]. However, only a few studies have focused on whether a second ejaculation can offer enough spermatozoa with progressive motility for IVF [19]. We compared the sperm quality between the two ejaculates. Then we comprehensively analyzed the clinical outcomes of the second ejaculation IVF and matched-conventional IVF. We showed that the second ejaculation could produce good quality sperm and blastocyst with a lower rate of application of ICSI in unexpected ICSI couples.
In the present study, we performed semen analysis between the first and second ejaculations. There was higher concentration, progressive motility, total progressive motility sperm count after swim-up, and lower SDF in the second ejaculation. Interestingly, about 53.5% of unexpected ICSI patients with second ejaculation were able to obtain sufficient progressive motility sperm for IVF. As is well known, ICSI cannot improve postfertilization reproductive outcomes compared with conventional IVF [20, 21]. Second ejaculation would allow us to increase the number of motile spermatozoa available to undergo IVF in cases of poor sperm for unexpected ICSI patients. Similar to our study, studies have indicated that an increase in motility and a decrease in SDF are associated with second ejaculation [16, 17]. It is not clear why the second ejaculation with a short abstinence period was associated with higher-quality sperm. Human spermatozoa are produced in the seminiferous tubules and are stored in the epididymis. One reasonable explanation might be that the second ejaculation is associated with shorter storage time in the epididymis and lower oxidative stress. Shortening exposure to reactive oxygen species arising from dead spermatozoa and leukocytes in the epididymis [22, 23] will lead to an increase in sperm quality and a decrease in SDF with second ejaculation. During epididymal transit, a series of elaborate interactions between spermatozoa and epididymal secretions occurs [24], which may influence flagellar beating and sperm motility [25]. Moreover, a bioinformatics analysis showed the differentially expressed proteins were enriched in sperm motility [18]. It may also be explained that spermatozoa play a major role in this process to improve sperm motility after a reduced period of male abstinence.
We detected lower concentration after swim-up and total progressive motile sperm count after swim-up between the ejaculation IVF group and conventional IVF before PSM. Given that sperm concentration and total progressive motile sperm count after swim-up may directly affect fertilization rate and cleavage rate as well as embryo quality, they are often correlated with negative pregnancy outcomes [26–29]. Moreover, many factors can influence the outcomes of IVF. Previous studies showed that female age, male age, number of oocytes retrieved, ovarian stimulation protocol, and infertility types were associated with the terms of fertilization rate, embryo quality rate, embryonic aneuploidy risk, and pregnancy outcomes [30–32]. In order to minimize the selection bias of baseline characteristics for conventional IVF and evaluate the effectiveness of second ejaculation IVF, we carried out PSM to balance all the baseline characteristics.
The current study found no difference in 2PN fertilization, total fertilization, rescue ICSI, cleavage, good quality embryo on day 3, and blastocyst formation rates between the second ejaculation IVF group and the matched-conventional IVF group. The good-quality blastocyst rate was significantly higher in the second ejaculation IVF group. Furthermore, our data showed that biochemical pregnancy, clinical pregnancy, implantation, live birth, and miscarriage rates were still not significantly different in the two groups. ICSI was originally applied to overcome the risk of low or total failed fertilization [33]. Patients with very poor semen characteristics on the day of ovum pick-up usually need to change to ICSI treatment. Although 53 out of 114 men in our study still need to undergo ICSI treatment. However, the second ejaculation had improved the total progressive motility of sperm, 53.5% of them within the range appropriate for IVF treatment. Moreover, the fertilization rate and rescue ICSI of second-ejaculation IVF patients were not different from those of matched-conventional IVF. This means that second ejaculation IVF can serve as an effective fertilization method without the increasing of unexpected ICSI. Furthermore, when evaluating the success of two kinds of IVF techniques, data showed no difference in clinical outcomes between second ejaculation IVF and matched-conventional IVF. These may suggest that second ejaculation is of greatest benefit in unexpected ICSI patients to decrease the application of ICSI, considering the high cost and additional required laboratory experience.
In this study, compared with the matched-conventional IVF group there was an increase in the good-quality blastocyst rate in the second ejaculation IVF group. In addition, both the univariate and multivariate analysis also confirmed that the second ejaculation was a risk factor for the good quality blastocyst rate. Second ejaculation can not only improve sperm quality by reducing the rate of unexpected ICSI but also provide higher-quality blastocysts for patients who have enough progressive sperm to undergo IVF. Our previous time-lapse sibling oocyte study found that significantly higher rate of high-quality blastocysts in the second ejaculation group compared with in the first ejaculation group [34]. A study on 106 sibling biopsied blastocysts also found that sperm with second ejaculation could reduce aneuploidy rate in blastocysts [35]. These studies are based on comparing the clinical outcomes of the first and second ejaculation of sibling oocyte study. Although sibling oocyte studies could minimize the bias caused by female factors, the difference in sperm progressive motility between two ejaculations could affect the outcome of embryonic development. In this study, we applied PSM to reduce the impact of basic parameters on blastocyst development and verified again with univariate and multivariate analysis. Interestingly, despite no difference being found in the progressive motility between the second ejaculation IVF group and matched-conventional IVF, we still found a significant increase in good-quality blastocyst obtained in the second ejaculation IVF group. On the one hand, the epididymis is exposed to a higher oxidative stress environment than elsewhere in the reproductive tract, and the second ejaculation with lower oxidative stress by storing in the epididymis for a shorter time. Many studies have shown that oxidative stress can lead to poor embryonic development, so lower oxidative stress of second ejaculation may be associated with good-quality embryos [36, 37]. On the other hand, the lower SDF in the second ejaculation may result in a good-quality blastocyst, supported by current studies that oocytes fertilized with damaged sperm DNA may exhibit a lower good-quality blastocyst rate [38, 39]. Therefore, second ejaculation IVF can improve the good quality blastocyst in unexpected ICSI patients.
Our study was limited by the small number of patients in the second ejaculation IVF group, which was more likely to produce research bias. Otherwise, the potential confounding factors of retrospective analysis are not all available, although PSM was performed to reduce biases between the two groups.
Conclusions
This study showed that a second ejaculation could be a simple, low-cost, and effective way to improve sperm, and blastocyst quality and also to decrease the rate of unexpected ICSI. However, further studies are needed to validate these findings.
Acknowledgements
We are grateful to all who participated in this study.
Authors’ contributions
Conceived and designed the study: XHZ, SKW, DWL and LTX. Performed the experiments: XHZ, YYH, XBM, ZDL, PPW and LSC. Analyzed the data: XHZ. Wrote the manuscript: XHZ. All authors read and approved the final manuscript.
Funding
The study was supported by self-funded Scientific Research Funded Project of Guangxi Zhuang Autonomous Health Commission (Z-A20220040 and Z-A20210746), the Key Research and Development Programme in Qingxiu District, Nanning (2019034) and Youth Found of the people’s hospital of Guangxi Zhuang Autonomous Region (QN2018-5).
Declarations
Ethics approval and consent to participate
All procedures were performed in accordance with the ethical standards of the ethics committee of our hospital (No: LL-KY-ZC-2021-02) and with the 1964 Declaration of Helsinki and its later amendments.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Abbreviations
Intracytoplsmic sperm injection
Propensity score-matched
In vitro fertilization
Sperm DNA fragmentation
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
1. Goss, D; Ayad, B; van der Horst, G; Skosana, B; du Plessis, SS. Improved sperm motility after 4 h of ejaculatory abstinence: role of accessory sex gland secretions. Reprod Fertil Dev; 2019; 31,
2. Hanson, BM; Aston, KI; Jenkins, TG; Carrell, DT; Hotaling, JM. The impact of ejaculatory abstinence on semen analysis parameters: a systematic review. J Assist Reprod Genet; 2018; 35,
3. Li, J; Shi, Q; Li, X; Guo, J; Zhang, L et al. The effect of male sexual abstinence periods on the clinical outcomes of fresh embryo transfer cycles following assisted reproductive technology: a meta-analysis. Am J Mens Health; 2020; 14,
4. Bahadur, G; Almossawi, O; Zeirideen Zaid, R et al. Semen characteristics in consecutive ejaculates with short abstinence in subfertile males. Reprod Biomed Online; 2016; 32,
5. Manna, C; Barbagallo, F; Manzo, R; Rahman, A; Francomano, D; Calogero, AE. Sperm parameters before and after swim-up of a second ejaculate after a short period of abstinence. J Clin Med; 2020; 9,
6. Palermo, G; Joris, H; Devroey, P; Van Steirteghem, AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet; 1992; 340, pp. 17-8.[COI: 1:STN:280:DyaK38zgtFWrsA%3D%3D] [DOI: https://dx.doi.org/10.1016/0140-6736(92)92425-f] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1351601]
7. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Electronic address: [email protected]. Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion. Fertil Steril. 2020;114:239–45. https://doi.org/10.1016/j.fertnstert.2020.05.032
8. Liu, L; Wang, H; Li, Z; Niu, J; Tang, R. Obstetric and perinatal outcomes of intracytoplasmic sperm injection versus conventional in vitro fertilization in couples with nonsevere male infertility. Fertil Steril; 2020; 114, pp. 792-800. [DOI: https://dx.doi.org/10.1016/j.fertnstert.2020.04.058] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32896391]
9. Zheng, D; Zeng, L; Yang, R; Lian, Y; Zhu, YM; Liang, X et al. Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial. BMJ Open; 2019; 9, e030366. [DOI: https://dx.doi.org/10.1136/bmjopen-2019-030366] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31575574][PubMedCentral: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773417]
10. Van Der Westerlaken, LA; Helmerhorst, FM; Hermans, J; Naaktgeboren, N. Intracytoplasmic sperm injection: position of the polar body affects pregnancy rate. Hum Reprod; 1999; 14,
11. Coates, A; Hesla, JS; Hurliman, A et al. Use of suboptimal sperm increases the risk of aneuploidy of the sex chromosomes in preimplantation blastocyst embryos. Fertil Steril; 2015; 104,
12. Esteves, SC; Roque, M; Bedoschi, G; Haahr, T; Humaidan, P. Intracytoplasmic sperm injection for male infertility and consequences for offspring. Nat Rev Urol; 2018; 15,
13. Catford, SR; McLachlan, RI; O'Bryan, MK; Halliday, JL. Long-term follow-up of intra-cytoplasmic sperm injection-conceived offspring compared with in vitro fertilization-conceived offspring: a systematic review of health outcomes beyond the neonatal period. Andrology; 2017; 5,
14. Massaro, PA; MacLellan, DL; Anderson, PA; Romao, RL. Does intracytoplasmic sperm injection pose an increased risk of genitourinary congenital malformations in offspring compared to in vitro fertilization? A systematic review and meta-analysis. J Urol; 2015; 193,
15. Chinese expert consensus on intracytoplasmic sperm injection (2023). Chin J Reprod Contracept. 2023;43(7):659-669. https://doi.org/10.3760/cma.j.cn101441-20230228-00076.
16. Dahan, MH; Mills, G; Khoudja, R; Gagnon, A; Tan, G; Tan, SL. Three hour abstinence as a treatment for high sperm DNA fragmentation: a prospective cohort study. J Assist Reprod Genet; 2021; 38,
17. Ayad, BM; Horst, GV; Plessis, SSD. Revisiting the relationship between the ejaculatory abstinence period and semen characteristics. Int J Fertil Steril; 2018; 11,
18. Shen, ZQ; Shi, B; Wang, TR et al. Characterization of the sperm proteome and reproductive outcomes with in vitro, fertilization after a reduction in male ejaculatory abstinence period. Mol Cell Proteomics; 2019; 18,
19. Bar-Hava, I; Perri, T; Ashkenazi, J; Shelef, M; Ben-Rafael, Z; Orvieto, R. The rationale for requesting a second consecutive sperm ejaculate for assisted reproductive technology. Gynecol Endocrinol; 2000; 14,
20. Dang, VQ; Vuong, LN; Luu, TM et al. Intracytoplasmic sperm injection versus conventional in-vitro fertilisation in couples with infertility in whom the male partner has normal total sperm count and motility: an open-label, randomised controlled trial. Lancet; 2021; 397,
21. Geng, T; Cheng, L; Ge, C; Zhang, Y. The effect of ICSI in infertility couples with non-male factor: a systematic review and meta-analysis. J Assist Reprod Genet; 2020; 37,
22. Borges, E, Jr; Braga, DPAF; Zanetti, BF; Iaconelli, A, Jr; Setti, AS. Revisiting the impact of ejaculatory abstinence on semen quality and intracytoplasmic sperm injection outcomes. Andrology; 2019; 7,
23. Comar, VA; Petersen, CG; Mauri, AL et al. Influence of the abstinence period on human sperm quality: analysis of 2,458 semen samples. JBRA Assist Reprod; 2017; 21,
24. James, ER; Carrell, DT; Aston, KI; Jenkins, TG; Yeste, M et al. The Role of the Epididymis and the Contribution of Epididymosomes to Mammalian Reproduction. Int J Mol Sci; 2020; 21,
25. Sullivan, R; Mieusset, R. The human epididymis: its function in sperm maturation. Hum Reprod Update; 2016; 22,
26. Bartolacci, A; Pagliardini, L; Makieva, S; Salonia, A; Papaleo, E; Viganò, P. Abnormal sperm concentration and motility as well as advanced paternal age compromise early embryonic development but not pregnancy outcomes: a retrospective study of 1266 ICSI cycles. J Assist Reprod Genet; 2018; 35,
27. Borges, E, Jr; Setti, AS; Braga, DP; Figueira, RC; Iaconelli, A, Jr. Total motile sperm count has a superior predictive value over the WHO 2010 cut-off values for the outcomes of intracytoplasmic sperm injection cycles. Andrology; 2016; 4,
28. Vogiatzi, P; Pouliakis, A; Sakellariou, M et al. Male Age and Progressive Sperm Motility Are Critical Factors Affecting Embryological and Clinical Outcomes in Oocyte Donor ICSI Cycles. Reprod Sci; 2022; 29,
29. Chua, AC; Abdul Karim, AK; Tan, ACC; Abu, MA; Ahmad, MF. The outcome of intra-cytoplasmic sperm injection (ICSI): do the sperm concentration and motility matter?. Horm Mol Biol Clin Investig; 2021; 42,
30. Polyzos, NP; Drakopoulos, P; Parra, J et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women. Fertil Steril; 2018; 110,
31. Law, YJ; Zhang, N; Venetis, CA; Chambers, GM; Harris, K. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles. Hum Reprod; 2019; 34,
32. Pacchiarotti, A; Selman, H; Valeri, C et al. Ovarian stimulation protocol in IVF: an up-to-date review of the literature. Curr Pharm Biotechnol; 2016; 17,
33. Bhattacharya, S; Maheshwari, A; Mollison, J. Factors associated with failed treatment: an analysis of 121,744 women embarking on their first IVF cycles. PLoS One; 2013; 8,
34. Li Y, Wang S, Li D, et al. Short-interval second ejaculation improves sperm quality, blastocyst formation in oligoasthenozoospermic males in ICSI cycles: a time-lapse sibling oocytes study. Front Endocrinol (Lausanne). 2023;14:1250663. Published 2023 Sep 7. https://doi.org/10.3389/fendo.2023.1250663
35. Scarselli, F; Cursio, E; Muzzì, S et al. How 1 h of abstinence improves sperm quality and increases embryo euploidy rate after PGT-A: a study on 106 sibling biopsied blastocysts. J Assist Reprod Genet; 2019; 36,
36. Bisht, S; Faiq, M; Tolahunase, M; Dada, R. Oxidative stress and male infertility. Nat Rev Urol; 2017; 14,
37. Wyck, S; Herrera, C; Requena, CE et al. Oxidative stress in sperm affects the epigenetic reprogramming in early embryonic development. Epigenet Chromatin; 2018; 11,
38. Wang H, Li H, Zhu J, et al. The Effect of Sperm DNA Fragmentation on In Vitro Fertilization Outcomes for Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2022;13:822786. Published 2022 May 27. https://doi.org/10.3389/fendo.2022.822786
39. Wang, S; Tan, W; Huang, Y et al. Sperm DNA fragmentation measured by sperm chromatin dispersion impacts morphokinetic parameters, fertilization rate and blastocyst quality in ICSI treatments. Zygote; 2022; 30,
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background
Second ejaculation can influence sperm quality which may define the first-line treatment. The purpose of this study was to evaluate the effectiveness of a second ejaculation in decreasing the unexpected intracytoplasmic sperm injection (ICSI) rate by a propensity score-matched (PSM) analysis.
Methods
Patients who were projected to undergo IVF were included between January 2016 and November 2021 in this monocentric, retrospective analysis. 2782 patients included in the study, 143 and 2639 patients were non-randomized in the unexpected ICSI and IVF groups, respectively. One hundred fourteen patients with unexpected ICSI produced two semen samples on the day of ovum pick-up. After 1:4 PSM, we matched 61 patients in the second ejaculation IVF group to 238 patients in the conventional IVF group. Outcomes of sperm quality, fertilization rate, embryo quality, and pregnancy were compared.
Results
Second ejaculation significantly improved sperm concentration, progressive motility before and after sperm swim-up, total progressive motility sperm count after swim-up, and decreased sperm DNA fragmentation (SDF). Sixty-one of 114 (53.5%) unexpected ICSI couples had enough total progressive motility sperm for IVF with the second ejaculation. There were no differences in basic clinical characteristics between couples in second ejaculation IVF and matched-conventional IVF group. For the two groups, no differences were observed in IVF outcomes. However, a significant increase in good-quality blastocyst rate was observed for second-ejaculation IVF couples. Univariate and multivariate linear regression analysis also confirmed that the second ejaculation was an independent risk factor for the good quality blastocyst rate.
Conclusion
Second ejaculation could be an economical and secure alternative to get good quality sperm, and blastocyst and decrease the rate of unexpected ICSI. Multicenter studies should be conducted to confirm the potential advantages of using second ejaculation IVF in effectively reducing the rate of ICSI.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Guangxi Academy of Medical Sciences, The People’s Hospital of Guangxi Zhuang Autonomous Region, Reproductive Medical and Genetic Center, Nanning, China (GRID:grid.410652.4) (ISNI:0000 0004 6003 7358)